Further studies are needed to determine whether BA profiling can serve also in risk stratification of subjects who are at higher risk of CCA development and to better characterise their role in promoting aberrant glycosylation profiles of MUC5AC in healthy and malignant cell lines. The gene discussed is MUC5AC; the disease is cholangiocarcinoma.